BACKGROUND Elderly patients (age> 65 years) with glioblastoma multiforme frequently are
excluded from clinical studies, and prospective trials for patients with this age group do not …

Objectives The optimal treatment for elderly patients (age> 70 years) with glioblastoma
remains controversial. We conducted a prospective trial in 32 consecutive elderly patients …

Background Glioblastoma is associated with a poor prognosis in the elderly. Survival has
been shown to increase among patients 70 years of age or younger when temozolomide …

The aim of this study was to evaluate the impact of radiotherapy plus concomitant and
adjuvant temozolomide (TMZ), in terms of feasibility and activity, in elderly patients with …

Purpose: Elderly patients make up a large percentage of the individuals newly diagnosed
with glioblastoma (gbm), but they face particular challenges in tolerating standard therapy …

PURPOSE: Radiotherapy (RT) and chemotherapy may prolong survival in older patients
(age≥ 70 years) with glioblastoma multiforme (GBM), although the survival benefits remain …

Introduction Elderly patients have glioblastomas (GBM) that are aggressive and poorly
responsive to treatment. They are also prone to the side effects of treatment of GBM …

Survival of elderly patients with glioblastoma (GBM) is poor, but improves with tumor
resection and radiotherapy (RT). Concurrent temozolomide (TMZ) chemotherapy during RT …

LBA2002 Background: Despite treatment advances, survival of elderly GBM patients (pts) is
usually< 12 months. Hypofractionated RT is advocated in order to shorten treatment time …

Elderly patients have largely been excluded from randomized trials for glioblastoma
multiforme (GBM). We reviewed the results of treatment approaches, which included …